SEC Company Response from Fortress Biotech, (FBIO) — Dec 16, 2025
Fortress Biotech, Inc.
Date: Dec. 16, 2025 · CIK: 0001429260 · Accession: 0001104659-25-121548
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292154
Letter
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
VIA EDGAR
December 16, 2025
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Tim Buchmiller
Re: Fortress Biotech, Inc.
Registration Statement on Form S-1
File No. 333-292154
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the " Company ") hereby requests that the Securities and Exchange Commission (the " Commission ") accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the " Registration Statement ") so that the Registration Statement will be declared effective as of 4:00 p.m. Eastern time, on December 17, 2025, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or David S. Wolpa, both of whom are attorneys at the Company's outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Wolpa at (704) 916-2375.
Thank you for your assistance in this matter.
Very truly yours,
Fortress Biotech, Inc.
Show Raw Text
CORRESP 1 filename1.htm Fortress Biotech, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands, Florida 33154 VIA EDGAR December 16, 2025 Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Tim Buchmiller Re: Fortress Biotech, Inc. Registration Statement on Form S-1 File No. 333-292154 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the " Company ") hereby requests that the Securities and Exchange Commission (the " Commission ") accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the " Registration Statement ") so that the Registration Statement will be declared effective as of 4:00 p.m. Eastern time, on December 17, 2025, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or David S. Wolpa, both of whom are attorneys at the Company's outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Wolpa at (704) 916-2375. Thank you for your assistance in this matter. Very truly yours, Fortress Biotech, Inc. /s/ David Jin Name: David Jin Title: Chief Financial Officer cc (via email): Rakesh Gopalan and David Wolpa, Troutman Pepper Locke LLP